Gene · 1022
Papers3,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of CD4/6 Inhibitors in Breast Cancer Treatment. | Int J Mol Sci | 2024 | 38279242 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs. | NPJ Precis Oncol | 2024 | 38273014 | PubTator, text mining | PubMed |
| Hamartoma of the soft palate: Case report and review of literature. | Int J Surg Case Rep | 2024 | 38266364 | PubTator, text mining | PubMed |
| Seize the engine: Emerging cell cycle targets in breast cancer. | Clin Transl Med | 2024 | 38264947 | PubTator, text mining | PubMed |
| Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia. | J Enzyme Inhib Med Chem | 2024 | 38258519 | PubTator, text mining | PubMed |
| Recent Advances in Pyrimidine-Based Drugs. | Pharmaceuticals (Basel) | 2024 | 38256937 | PubTator, text mining | PubMed |
| Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro. | Int J Mol Sci | 2024 | 38255960 | PubTator, text mining | PubMed |
| New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care. | Life (Basel) | 2024 | 38255719 | PubTator, text mining | PubMed |
| 17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications. | Cancers (Basel) | 2024 | 38254827 | PubTator, text mining | PubMed |
| Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer. | BMC Med Genomics | 2024 | 38243290 | PubTator, text mining | PubMed |
| Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma. | Cancer Biol Ther | 2024 | 38230570 | PubTator, text mining | PubMed |
| Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. | Clin Transl Med | 2024 | 38214432 | PubTator, text mining | PubMed |
| Advances in invasive micropapillary carcinoma of the breast research: A review. | Medicine (Baltimore) | 2024 | 38181281 | PubTator, text mining | PubMed |
| Live-cell imaging of endogenous CSB-mScarletI as a sensitive marker for DNA-damage-induced transcription stress. | Cell Rep Methods | 2024 | 38176411 | PubTator, text mining | PubMed |
| Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemia. | Anticancer Drugs | 2024 | 38164802 | PubTator, text mining | PubMed |
| Deep Learning Prediction Boosts Phosphoproteomics-Based Discoveries Through Improved Phosphopeptide Identification. | Mol Cell Proteomics | 2024 | 38154692 | PubTator, text mining | PubMed |
| Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling. | Mol Cell Proteomics | 2024 | 38122900 | PubTator, text mining | PubMed |
| Reprogramming and multi-lineage transdifferentiation attenuate the tumorigenicity of colorectal cancer cells. | J Biol Chem | 2024 | 38072050 | PubTator, text mining | PubMed |
| The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. | J Biol Chem | 2024 | 38016516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1022/papers?page=12